GSK licenses rights to Human Genome Sciences' Albugon
Executive Summary
In its largest deal yet, Human Genome Sciences licensed GlaxoSmithKline exclusive worldwide development and commercialization rights to Albugon (albumin GLP-1) for all therapeutic and prophylactic applications.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice